BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127-148. [PMID: 26907531 DOI: 10.1146/annurev-pathol-012615-044152] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 21.2] [Reference Citation Analysis]
Number Citing Articles
1 Huynh E, Akhtar N, Li J. Efficient Production of Recombinant Protegrin-1 From Pichia pastoris, and Its Antimicrobial and in vitro Cell Migration Activity. Front Microbiol 2018;9:2300. [PMID: 30319593 DOI: 10.3389/fmicb.2018.02300] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
2 Lamas B, Richard ML, Sokol H. Caspase recruitment domain 9, microbiota, and tryptophan metabolism: dangerous liaisons in inflammatory bowel diseases. Curr Opin Clin Nutr Metab Care 2017;20:243-7. [PMID: 28399013 DOI: 10.1097/MCO.0000000000000382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Peng S, Shen L, Tian MX, Li HM, Wang SS. Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway. Exp Ther Med 2021;21:134. [PMID: 33376516 DOI: 10.3892/etm.2020.9566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Li J, Bao J, Zeng J, Yan A, Zhao C, Shu Q. Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. Bone Res 2019;7:27. [PMID: 31646017 DOI: 10.1038/s41413-019-0067-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Haring E, Zeiser R, Apostolova P. Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease. Front Immunol 2021;12:705342. [PMID: 34249014 DOI: 10.3389/fimmu.2021.705342] [Reference Citation Analysis]
6 Ruiz E, Penrose HM, Heller S, Nakhoul H, Baddoo M, Flemington EF, Kandil E, Savkovic SD. Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease. Gut Microbes 2020;11:350-63. [PMID: 31063017 DOI: 10.1080/19490976.2019.1611152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhu X, Xiang S, Feng X, Wang H, Tian S, Xu Y, Shi L, Yang L, Li M, Shen Y, Chen J, Chen Y, Han J. Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition. J Agric Food Chem 2019;67:916-26. [DOI: 10.1021/acs.jafc.8b05730] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
8 Espaillat MP, Snider AJ, Qiu Z, Channer B, Coant N, Schuchman EH, Kew RR, Sheridan BS, Hannun YA, Obeid LM. Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment. FASEB J 2018;32:2339-53. [PMID: 29259036 DOI: 10.1096/fj.201700585R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
9 Zhou G, Yang W, Yu L, Yu T, Liu Z. CD99 refers to the activity of inflammatory bowel disease. Scand J Gastroenterol 2017;52:359-64. [PMID: 27866429 DOI: 10.1080/00365521.2016.1256426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wu Z, Yang J, Chen L, Du C, Zhang Q, Zhao S, Wang X, Yang J, Liu Y, Cai D, Du J, Liu H. Short-Term High-Fat Diet Fuels Colitis Progression in Mice Associated With Changes in Blood Metabolome and Intestinal Gene Expression. Front Nutr 2022;9:899829. [DOI: 10.3389/fnut.2022.899829] [Reference Citation Analysis]
11 Fois CAM, Le TYL, Schindeler A, Naficy S, McClure DD, Read MN, Valtchev P, Khademhosseini A, Dehghani F. Models of the Gut for Analyzing the Impact of Food and Drugs. Adv Healthc Mater 2019;8:e1900968. [PMID: 31592579 DOI: 10.1002/adhm.201900968] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
12 Borody TJ, Dolai S, Gunaratne AW, Clancy RL. Targeting the microbiome in Crohn's disease. Expert Rev Clin Immunol 2022. [PMID: 35731859 DOI: 10.1080/1744666X.2022.2093186] [Reference Citation Analysis]
13 Kung VL, Liu T, Ma C. Collagenous Enteritis is Unlikely a Form of Aggressive Celiac Disease Despite Sharing HLA-DQ2/DQ8 Genotypes. American Journal of Surgical Pathology 2018;42:545-52. [DOI: 10.1097/pas.0000000000001022] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
14 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
15 Ye M, Joosse ME, Liu L, Sun Y, Dong Y, Cai C, Song Z, Zhang J, Brant SR, Lazarev M, Li X. Deletion of IL-6 Exacerbates Colitis and Induces Systemic Inflammation in IL-10-Deficient Mice. J Crohns Colitis 2020;14:831-40. [PMID: 31679013 DOI: 10.1093/ecco-jcc/jjz176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
16 Liu TC, Naito T, Liu Z, VanDussen KL, Haritunians T, Li D, Endo K, Kawai Y, Nagasaki M, Kinouchi Y, McGovern DP, Shimosegawa T, Kakuta Y, Stappenbeck TS. LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients. JCI Insight 2017;2:e91917. [PMID: 28352666 DOI: 10.1172/jci.insight.91917] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
17 Yao Y, Feng Q, Shen J. Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn's disease. Expert Rev Clin Immunol 2020;16:1127-41. [PMID: 33183108 DOI: 10.1080/1744666X.2021.1850269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
19 Lopes F, Matisz C, Reyes JL, Jijon H, Al-darmaki A, Kaplan GG, Mckay DM. Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis. Inflammatory Bowel Diseases 2016;22:2499-512. [DOI: 10.1097/mib.0000000000000889] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
20 Shen Q, Huang Z, Yao J, Jin Y. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ohno M, Hasegawa M, Hayashi A, Caballero-Flores G, Alteri CJ, Lawley TD, Kamada N, Núñez G, Inohara N. Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3. PLoS Pathog 2020;16:e1008928. [PMID: 33027280 DOI: 10.1371/journal.ppat.1008928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A 2019;116:12672-7. [PMID: 31182571 DOI: 10.1073/pnas.1904099116] [Cited by in Crossref: 110] [Cited by in F6Publishing: 110] [Article Influence: 36.7] [Reference Citation Analysis]
23 Mari A, Khoury T, Ahamad HS, Bragazzi NL, Sbeit W, Mahamid A, Mahamid L, Nesseir W, Baker FA, Pellicano R, Amital H, Watad A, Mahamid M. Autoimmune diseases in first- and second-degree relatives of patients with inflammatory bowel diseases: a case-control survey in Israel. Minerva Med 2020;111. [DOI: 10.23736/s0026-4806.19.06389-4] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Chen K, Shao LH, Wang F, Shen XF, Xia XF, Kang X, Song P, Wang M, Lu XF, Wang C, Hu QY, Liu S, Guan WX. Netting Gut Disease: Neutrophil Extracellular Trap in Intestinal Pathology. Oxid Med Cell Longev 2021;2021:5541222. [PMID: 34712384 DOI: 10.1155/2021/5541222] [Reference Citation Analysis]
25 Ashour RH, Hazem NM, AbdElfattah AA, El-Kady RA, Elmasry A. Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression. Int Immunopharmacol 2022;106:108620. [PMID: 35247859 DOI: 10.1016/j.intimp.2022.108620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Miyoshi J, Bobe AM, Miyoshi S, Huang Y, Hubert N, Delmont TO, Eren AM, Leone V, Chang EB. Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring. Cell Rep. 2017;20:491-504. [PMID: 28700948 DOI: 10.1016/j.celrep.2017.06.060] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 14.5] [Reference Citation Analysis]
28 Espaillat MP, Kew RR, Obeid LM. Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul 2017;63:140-55. [PMID: 27866974 DOI: 10.1016/j.jbior.2016.11.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
29 Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: Concept, Design, and Applications. Chem Rev 2020;120:3787-851. [PMID: 32202104 DOI: 10.1021/acs.chemrev.9b00738] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 28.5] [Reference Citation Analysis]
30 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
31 Pan LL, Ren Z, Liu Y, Zhao Y, Li H, Pan X, Fang X, Liang W, Wang Y, Yang J, Sun J. A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation. J Cell Mol Med 2020;24:12955-69. [PMID: 32945118 DOI: 10.1111/jcmm.15890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Han C, Guan Q, Guo L, Yang Y, Ruan S, Zhang X. The effects and mechanisms of myeloid differentiation protein 2 on intestinal mucosal permeability in mice with chronic colitis. J Cell Physiol 2019;234:21089-99. [PMID: 31032920 DOI: 10.1002/jcp.28711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
33 Li JY, Xiao J, Gao M, Zhou HF, Fan H, Sun F, Cui DD. IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. Int Immunopharmacol 2021;92:107350. [PMID: 33444921 DOI: 10.1016/j.intimp.2020.107350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Morsy Y, Brillant N, Franc Y, Scharl M, Wawrzyniak M, On Behalf Of The Swiss Ibd Cohort Study Group. Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease. Cells 2021;10:3589. [PMID: 34944097 DOI: 10.3390/cells10123589] [Reference Citation Analysis]
35 Elhenawy W, Oberc A, Coombes BK. A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli. Gut Microbes 2018;9:166-74. [PMID: 28914579 DOI: 10.1080/19490976.2017.1378291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
36 Zhang X, Wei L, Wang J, Qin Z, Lu Y, Zheng X, Peng Q, Ye Q, Ai F, Liu P, Wang S, Li G, Shen S, Ma J. Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Front Immunol. 2017;8:1774. [PMID: 29326691 DOI: 10.3389/fimmu.2017.01774] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
37 Wang K, Yang Q, Ma Q, Wang B, Wan Z, Chen M, Wu L. Protective Effects of Salvianolic Acid A against Dextran Sodium Sulfate-Induced Acute Colitis in Rats. Nutrients. 2018;10:791. [PMID: 29921812 DOI: 10.3390/nu10060791] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
38 Chao CY, Battat R, Al Khoury A, Restellini S, Sebastiani G, Bessissow T. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. World J Gastroenterol 2016; 22(34): 7727-7734 [PMID: 27678354 DOI: 10.3748/wjg.v22.i34.7727] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
39 Penrose HM, Iftikhar R, Collins ME, Toraih E, Ruiz E, Ungerleider N, Nakhoul H, Flemington EF, Kandil E, Shah SB, Savkovic SD. Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy. Sci Rep 2021;11:9010. [PMID: 33907256 DOI: 10.1038/s41598-021-88489-w] [Reference Citation Analysis]
40 Bian Y, Liu P, Zhong J, Hu Y, Zhuang S, Fan K, Liu Z. Quercetin Attenuates Adhesion Molecule Expression in Intestinal Microvascular Endothelial Cells by Modulating Multiple Pathways. Dig Dis Sci 2018;63:3297-304. [PMID: 30076503 DOI: 10.1007/s10620-018-5221-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
41 Asadzadeh-Aghdaei H, Mashayekhi K, Koushki K, Azimzadeh P, Rostami-Nejad M, Amani D, Chaleshi V, Haftcheshmeh SM, Sahebkar A, Zali MR. V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. J Cell Biochem 2019;120:15746-55. [PMID: 31069840 DOI: 10.1002/jcb.28844] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ntunzwenimana JC, Boucher G, Paquette J, Gosselin H, Alikashani A, Morin N, Beauchamp C, Thauvette L, Rivard MÈ, Dupuis F, Deschênes S, Foisy S, Latour F, Lavallée G, Daly MJ, Xavier RJ, Charron G, Goyette P, Rioux JD; iGenoMed Consortium. Functional screen of inflammatory bowel disease genes reveals key epithelial functions. Genome Med 2021;13:181. [PMID: 34758847 DOI: 10.1186/s13073-021-00996-7] [Reference Citation Analysis]
43 Seifert LL, Si C, Saha D, Sadic M, de Vries M, Ballentine S, Briley A, Wang G, Valero-Jimenez AM, Mohamed A, Schaefer U, Moulton HM, García-Sastre A, Tripathi S, Rosenberg BR, Dittmann M. The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response. PLoS Pathog 2019;15:e1007634. [PMID: 31682641 DOI: 10.1371/journal.ppat.1007634] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
44 Fraiberg M, Elazar Z. Genetic defects of autophagy linked to disease. Prog Mol Biol Transl Sci 2020;172:293-323. [PMID: 32620246 DOI: 10.1016/bs.pmbts.2020.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Fan F, Ai Y, Sun T, Li S, Liu H, Shi X, Zhang Z, Liu Q, Cheng Y. The role of inflammatory cytokines in anemia and gastrointestinal mucosal injury induced by foot electric stimulation. Sci Rep 2021;11:3101. [PMID: 33542312 DOI: 10.1038/s41598-021-82604-7] [Reference Citation Analysis]
46 Restellini S, Chazouillères O, Frossard JL. Hepatic manifestations of inflammatory bowel diseases. Liver Int 2017;37:475-89. [PMID: 27712010 DOI: 10.1111/liv.13265] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
47 Gao L, Yu Q, Zhang H, Wang Z, Zhang T, Xiang J, Yu S, Zhang S, Wu H, Xu Y, Wang Z, Shen L, Shu G, Chen YG, Liu H, Shen L, Li B. A resident stromal cell population actively restrains innate immune response in the propagation phase of colitis pathogenesis in mice. Sci Transl Med 2021;13:eabb5071. [PMID: 34290057 DOI: 10.1126/scitranslmed.abb5071] [Reference Citation Analysis]
48 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
49 Wang Z, Shi W, Tian D, Qin H, Vallance BA, Yang H, Yu HB, Yu Q. Autotaxin stimulates LPA2 receptor in macrophages and exacerbates dextran sulfate sodium-induced acute colitis. J Mol Med (Berl) 2020;98:1781-94. [PMID: 33128578 DOI: 10.1007/s00109-020-01997-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Shen Y, Zhou M, Yan J, Gong Z, Xiao Y, Zhang C, Du P, Chen Y. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro.Am J Physiol Gastrointest Liver Physiol. 2017;312:G123-G132. [PMID: 27979826 DOI: 10.1152/ajpgi.00316.2016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
51 Morsy MA, Gupta S, Nair AB, Venugopala KN, Greish K, El-Daly M. Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats. Nutrients 2019;11:E2309. [PMID: 31569451 DOI: 10.3390/nu11102309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Uniken Venema WT, Voskuil MD, Dijkstra G, Weersma RK, Festen EA. The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol. 2017;241:146-158. [PMID: 27785786 DOI: 10.1002/path.4817] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
53 Shi W, Xu N, Wang X, Vallée I, Liu M, Liu X. Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives. JIR 2022;Volume 15:475-91. [DOI: 10.2147/jir.s348079] [Reference Citation Analysis]
54 Allez M, Auzolle C, Ngollo M, Bottois H, Chardiny V, Corraliza AM, Salas A, Perez K, Stefanescu C, Nancey S, Buisson A, Pariente B, Fumery M, Sokol H, Tréton X, Barnich N, Seksik P, Le Bourhis L; REMIND Study Group. T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence. Gut 2019;68:1961-70. [PMID: 30792246 DOI: 10.1136/gutjnl-2018-317878] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
55 Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci 2021;22:5421. [PMID: 34063828 DOI: 10.3390/ijms22115421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ponce de León-rodríguez MDC, Guyot J, Laurent-babot C. Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation. Critical Reviews in Food Science and Nutrition 2019;59:3648-66. [DOI: 10.1080/10408398.2018.1506734] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
57 Chandan K, Gupta M, Sarwat M. Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases. Front Immunol 2019;10:3081. [PMID: 32038627 DOI: 10.3389/fimmu.2019.03081] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
58 Lin A, Roth H, Anyane-Yeboa A, Rubin DT, Paul S. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2021;27:947-55. [PMID: 32780094 DOI: 10.1093/ibd/izaa189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
59 Lamas B, Richard ML, Sokol H. CARD9 et colite : un pont entre dysbiose et immunité. Med Sci (Paris) 2016;32:933-6. [DOI: 10.1051/medsci/20163211007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
60 Ma H, Tao W, Zhu S. T lymphocytes in the intestinal mucosa: defense and tolerance. Cell Mol Immunol 2019;16:216-24. [PMID: 30787416 DOI: 10.1038/s41423-019-0208-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
61 Polari L, Anttila S, Helenius T, Wiklund A, Linnanen T, Toivola DM, Määttä J. Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis. Int J Mol Sci 2019;20:E3007. [PMID: 31226730 DOI: 10.3390/ijms20123007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Liu XH, Wu XR, Lan N, Zheng XB, Zhou C, Hu T, Chen YF, Cai ZR, Chen ZX, Lan P, Wu XJ. CD73 promotes colitis-associated tumorigenesis in mice. Oncol Lett 2020;20:1221-30. [PMID: 32724362 DOI: 10.3892/ol.2020.11670] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Small CL, Xing L, McPhee JB, Law HT, Coombes BK. Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period. PLoS Pathog. 2016;12:e1005907. [PMID: 27711220 DOI: 10.1371/journal.ppat.1005907] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
64 Yan Y, Li Y, Lv M, Li W, Shi HN. Role of p40phox in host defense against Citrobacter rodentium infection. FEBS Open Bio 2021;11:1476-86. [PMID: 33780601 DOI: 10.1002/2211-5463.13155] [Reference Citation Analysis]
65 Andreou NP, Legaki E, Gazouli M. Inflammatory bowel disease pathobiology: the role of the interferon signature. Ann Gastroenterol 2020;33:125-33. [PMID: 32127733 DOI: 10.20524/aog.2020.0457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
66 Seo KI, Kang SB. [Hepatobiliary Manifestation of Inflammatory Bowel Disease]. Korean J Gastroenterol 2019;73:248-59. [PMID: 31132831 DOI: 10.4166/kjg.2019.73.5.248] [Reference Citation Analysis]
67 Dong S, Chen M, Dai F, Xuan Q, Chen P, Feng D, Gao L, Zhu C, Chang Y, Chu F, Gao Q. 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon. J Cell Biochem 2019;120:9230-42. [DOI: 10.1002/jcb.28198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
68 Cushing KC, Mclean R, McDonald KG, Gustafsson JK, Knoop KA, Kulkarni DH, Sartor RB, Newberry RD. Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients with Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery. Inflamm Bowel Dis. 2019;25:180-193. [PMID: 29982468 DOI: 10.1093/ibd/izy228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
69 Ma C, Storer CE, Chandran U, LaFramboise WA, Petrosko P, Frank M, Hartman DJ, Pantanowitz L, Haritunians T, Head RD, Liu TC. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer. EBioMedicine 2021;67:103347. [PMID: 33906066 DOI: 10.1016/j.ebiom.2021.103347] [Reference Citation Analysis]
70 Harris KG, Chang EB. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease. Clin Sci (Lond) 2018;132:2013-28. [PMID: 30232239 DOI: 10.1042/CS20171110] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
71 Robinson BS, Saeedi B, Arthur CM, Owens J, Naudin C, Ahmed N, Luo L, Jones R, Neish A, Stowell SR. Galectin-9 Is a Novel Regulator of Epithelial Restitution. Am J Pathol 2020;190:1657-66. [PMID: 32380082 DOI: 10.1016/j.ajpath.2020.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Nakamura T. Recent progress in organoid culture to model intestinal epithelial barrier functions. International Immunology 2019;31:13-21. [DOI: 10.1093/intimm/dxy065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
73 Zeng RZ, Lv XD, Liu GF, Gu GL, Li SQ, Chen L, Fan JH, Liang ZL, Wang HQ, Lu F, Zhan LL, Lv XP. The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population. Int J Gen Med 2021;14:9163-72. [PMID: 34880655 DOI: 10.2147/IJGM.S338142] [Reference Citation Analysis]
74 Huangfu S, Dou R, Zhong S, Guo M, Gu C, Jurczyszyn A, Yang Y, Jiang B. Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway. BMC Complement Med Ther 2020;20:179. [PMID: 32517784 DOI: 10.1186/s12906-020-02974-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
75 Stappenbeck TS, McGovern DPB. Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease. Gastroenterology 2017;152:322-6. [PMID: 27729212 DOI: 10.1053/j.gastro.2016.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
76 Teruel AH, Pérez-esteve É, González-álvarez I, González-álvarez M, Costero AM, Ferri D, Gaviña P, Merino V, Martínez-máñez R, Sancenón F. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Mol Pharmaceutics 2019;16:2418-29. [DOI: 10.1021/acs.molpharmaceut.9b00041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
77 Guo R, Meng Q, Wang B, Li F. Anti-inflammatory effects of Platycodin D on dextran sulfate sodium (DSS) induced colitis and E. coli Lipopolysaccharide (LPS) induced inflammation. Int Immunopharmacol 2021;94:107474. [PMID: 33611056 DOI: 10.1016/j.intimp.2021.107474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Zhou G, Wu W, Yu L, Yu T, Yang W, Wang P, Zhang X, Cong Y, Liu Z. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17 cell differentiation in patients with inflammatory bowel diseases. Journal of Allergy and Clinical Immunology 2018;142:1218-1228.e12. [DOI: 10.1016/j.jaci.2017.09.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
79 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 410] [Cited by in F6Publishing: 1] [Article Influence: 205.0] [Reference Citation Analysis]
80 van Beek N, Klionsky DJ, Reggiori F. Genetic aberrations in macroautophagy genes leading to diseases. Biochim Biophys Acta Mol Cell Res 2018;1865:803-16. [PMID: 29524522 DOI: 10.1016/j.bbamcr.2018.03.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
81 Wu WH, Zegarra-Ruiz DF, Diehl GE. Intestinal Microbes in Autoimmune and Inflammatory Disease. Front Immunol 2020;11:597966. [PMID: 33424846 DOI: 10.3389/fimmu.2020.597966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
82 Xue G, Gao R, Liu Z, Xu N, Cao Y, Zhao B, Du J. Vitamin D/VDR signaling inhibits colitis by suppressing HIF-1α activation in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2021;320:G837-46. [PMID: 33759562 DOI: 10.1152/ajpgi.00061.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
83 Liu TC, Kern JT, VanDussen KL, Xiong S, Kaiko GE, Wilen CB, Rajala MW, Caruso R, Holtzman MJ, Gao F, McGovern DP, Nunez G, Head RD, Stappenbeck TS. Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease. J Clin Invest 2018;128:5110-22. [PMID: 30137026 DOI: 10.1172/JCI120453] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
84 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
85 Aggeletopoulou I, Assimakopoulos SF, Konstantakis C, Triantos C. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease. World J Gastroenterol 2018;24:4093-103. [PMID: 30271076 DOI: 10.3748/wjg.v24.i36.4093] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
86 Nexoe AB, Pilecki B, Von Huth S, Husby S, Pedersen AA, Detlefsen S, Marcussen N, Moeller JB, Holmskov U, Sorensen GL. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1349-56. [PMID: 30753482 DOI: 10.1093/ibd/izz009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Khafipour A, Eissa N, Munyaka PM, Rabbi MF, Kapoor K, Kermarrec L, Khafipour E, Bernstein CN, Ghia JE. Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis. Front Microbiol 2020;11:1405. [PMID: 32670246 DOI: 10.3389/fmicb.2020.01405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 DeHaan RK, Sarvestani SK, Huang EH. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review. Dis Colon Rectum 2020;63:1559-69. [PMID: 32868555 DOI: 10.1097/DCR.0000000000001806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chang X, Wang SL, Zhao SB, Shi YH, Pan P, Gu L, Yao J, Li ZS, Bai Y. Extracellular Vesicles with Possible Roles in Gut Intestinal Tract Homeostasis and IBD. Mediators Inflamm 2020;2020:1945832. [PMID: 32410847 DOI: 10.1155/2020/1945832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
90 Chimenti MS, Conigliaro P, Biancone L, Perricone R. Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib. Ther Adv Musculoskelet Dis 2021;13:1759720X20977777. [PMID: 33680096 DOI: 10.1177/1759720X20977777] [Reference Citation Analysis]
91 Schneider C, O'Leary CE, von Moltke J, Liang HE, Ang QY, Turnbaugh PJ, Radhakrishnan S, Pellizzon M, Ma A, Locksley RM. A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 2018;174:271-284.e14. [PMID: 29887373 DOI: 10.1016/j.cell.2018.05.014] [Cited by in Crossref: 150] [Cited by in F6Publishing: 136] [Article Influence: 37.5] [Reference Citation Analysis]
92 Luo W, Tian L, Tan B, Shen Z, Xiao M, Wu S, Meng X, Wu X, Wang X. Update: Innate Lymphoid Cells in Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 33609209 DOI: 10.1007/s10620-021-06831-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kelleher M, Singh R, O'Driscoll CM, Melgar S. Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease. Cytokine Growth Factor Rev 2019;47:21-31. [PMID: 31133507 DOI: 10.1016/j.cytogfr.2019.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
94 Li G, Zhang B, Hao J, Chu X, Wiestler M, Cornberg M, Xu CJ, Liu X, Li Y. Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing. Cell Mol Gastroenterol Hepatol 2021;12:99-117. [PMID: 33545427 DOI: 10.1016/j.jcmgh.2021.01.020] [Reference Citation Analysis]
95 Chiba H, Kakuta Y, Kinouchi Y, Kawai Y, Watanabe K, Nagao M, Naito T, Onodera M, Moroi R, Kuroha M, Kanazawa Y, Kimura T, Shiga H, Endo K, Negoro K, Nagasaki M, Unno M, Shimosegawa T. Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease. PLoS One 2018;13:e0194036. [PMID: 29547621 DOI: 10.1371/journal.pone.0194036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
96 Henke MT, Brown EM, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus. Proc Natl Acad Sci U S A 2021;118:e2007595118. [PMID: 33972416 DOI: 10.1073/pnas.2007595118] [Cited by in Crossref: 1] [Reference Citation Analysis]
97 Ding A, Wen X. Dandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitis. J Nat Med 2018;72:857-66. [PMID: 29740735 DOI: 10.1007/s11418-018-1217-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
98 Boros É, Prontvai B, Kellermayer Z, Balogh P, Sarlós P, Vincze Á, Varga C, Maróti Z, Bálint B, Nagy I. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 2020;10:E974. [PMID: 32610492 DOI: 10.3390/biom10070974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 226] [Cited by in F6Publishing: 234] [Article Influence: 113.0] [Reference Citation Analysis]
100 Nadpara N, Reichenbach ZW, Ehrlich AC, Friedenberg F. Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications. Dig Dis Sci 2020;65:2769-79. [PMID: 32661765 DOI: 10.1007/s10620-020-06471-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
101 Singh K, Gobert AP, Coburn LA, Barry DP, Allaman M, Asim M, Luis PB, Schneider C, Milne GL, Boone HH, Shilts MH, Washington MK, Das SR, Piazuelo MB, Wilson KT. Dietary Arginine Regulates Severity of Experimental Colitis and Affects the Colonic Microbiome. Front Cell Infect Microbiol 2019;9:66. [PMID: 30972302 DOI: 10.3389/fcimb.2019.00066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
102 Miyoshi J, Lee STM, Kennedy M, Puertolas M, Frith M, Koval JC, Miyoshi S, Antonopoulos DA, Leone V, Chang EB. Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model. Cell Mol Gastroenterol Hepatol 2021;11:491-502. [PMID: 32835897 DOI: 10.1016/j.jcmgh.2020.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int 2017;2017:8201672. [PMID: 28831399 DOI: 10.1155/2017/8201672] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
104 Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017;198:564-71. [PMID: 28069751 DOI: 10.4049/jimmunol.1601621] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
105 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Reference Citation Analysis]
106 Han Y, Wang X, Cheng X, Zhao M, Zhao T, Guo L, Liu D, Wu K, Fan M, Shi M, Zhu L. Close Homolog of L1 Deficiency Exacerbated Intestinal Epithelial Barrier Function in Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Front Physiol 2020;11:584508. [PMID: 33240104 DOI: 10.3389/fphys.2020.584508] [Reference Citation Analysis]
107 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol 2019;41:747-56. [DOI: 10.1007/s00281-019-00751-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
109 Čalija B, Milić J. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017;67:124-42. [DOI: 10.5937/arhfarm1702124c] [Reference Citation Analysis]
110 Quintero M, Liu S, Xia Y, Huang Y, Zou Y, Li G, Hu L, Singh N, Blumberg R, Cai Y, Xu H, Li H. Cdk5rap3 is essential for intestinal Paneth cell development and maintenance. Cell Death Dis 2021;12:131. [PMID: 33504792 DOI: 10.1038/s41419-021-03401-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
111 Shao J, Li Z, Gao Y, Zhao K, Lin M, Li Y, Wang S, Liu Y, Chen L. Construction of a "Bacteria-Metabolites" Co-Expression Network to Clarify the Anti-Ulcerative Colitis Effect of Flavonoids of Sophora flavescens Aiton by Regulating the "Host-Microbe" Interaction. Front Pharmacol 2021;12:710052. [PMID: 34721011 DOI: 10.3389/fphar.2021.710052] [Reference Citation Analysis]
112 Shamoon M, Martin NM, O'Brien CL. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications. Pharmacol Res. 2019;148:104344. [PMID: 31400403 DOI: 10.1016/j.phrs.2019.104344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
113 Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases. Transl Res 2017;179:38-48. [PMID: 27371886 DOI: 10.1016/j.trsl.2016.06.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
114 Wang F, Peng PL, Lin X, Chang Y, Liu J, Zhou R, Nie JY, Dong WG, Zhao Q, Li J. Regulatory role of NKG2D+ NK cells in intestinal lamina propria by secreting double-edged Th1 cytokines in ulcerative colitis. Oncotarget 2017;8:98945-52. [PMID: 29228739 DOI: 10.18632/oncotarget.22132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
115 Yacoub R, Jacob A, Wlaschin J, Mcgregor M, Quigg RJ, Alexander JJ. Lupus: The microbiome angle. Immunobiology 2018;223:460-5. [DOI: 10.1016/j.imbio.2017.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
116 Zhang S, Cao L, Li Z, Qu D. Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis. Cancer Letters 2019;450:123-31. [DOI: 10.1016/j.canlet.2019.02.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
117 D'Haens GRAM, Lindsay JO, Panaccione R, Schreiber S. Ulcerative Colitis: Shifting Sands. Drugs R D 2019;19:227-34. [PMID: 30827006 DOI: 10.1007/s40268-019-0263-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
118 Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases. Cells 2019;8:E1573. [PMID: 31817238 DOI: 10.3390/cells8121573] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
119 McElrath C, Espinosa V, Lin JD, Peng J, Sridhar R, Dutta O, Tseng HC, Smirnov SV, Risman H, Sandoval MJ, Davra V, Chang YJ, Pollack BP, Birge RB, Galan M, Rivera A, Durbin JE, Kotenko SV. Critical role of interferons in gastrointestinal injury repair. Nat Commun 2021;12:2624. [PMID: 33976143 DOI: 10.1038/s41467-021-22928-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
120 Pagnini C, Cominelli F. Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention. Int J Mol Sci 2021;22:10273. [PMID: 34638616 DOI: 10.3390/ijms221910273] [Reference Citation Analysis]
121 You Y, Zhang X, Wang X, Yue D, Meng F, Zhu J, Wang Y, Sun X. ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1-/- Mouse through Promoting M2 Macrophage Polarization. J Immunol Res 2020;2020:5018975. [PMID: 32676507 DOI: 10.1155/2020/5018975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
122 AlKhater S. A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease. Allergy Asthma Clin Immunol 2019;15:68. [PMID: 31832070 DOI: 10.1186/s13223-019-0386-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Liu W, Wang C, Tang L, Yang H. Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis. Immunological Investigations. [DOI: 10.1080/08820139.2020.1787438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Baillie JK, Arner E, Daub C, De Hoon M, Itoh M, Kawaji H, Lassmann T, Carninci P, Forrest AR, Hayashizaki Y, Faulkner GJ, Wells CA, Rehli M, Pavli P, Summers KM, Hume DA; FANTOM Consortium. Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. PLoS Genet 2017;13:e1006641. [PMID: 28263993 DOI: 10.1371/journal.pgen.1006641] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
125 Nourian M, Chaleshi V, Pishkar L, Azimzadeh P, Baradaran Ghavami S, Balaii H, Alinaghi S, Shahrokh S, Asadzadeh Aghdaei H, Zali MR. Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseases. Biomed Rep 2017;6:698-702. [PMID: 28584644 DOI: 10.3892/br.2017.908] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
126 Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol 2016;51:853-61. [DOI: 10.1007/s00535-016-1220-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
127 Ala M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol 2021;:1-20. [PMID: 34289794 DOI: 10.1080/08830185.2021.1954638] [Reference Citation Analysis]
128 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
129 Li J, Pan X, Ren Z, Li B, Liu H, Wu C, Dong X, de Vos P, Pan LL, Sun J. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium-induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation. Br J Pharmacol 2021. [PMID: 34599829 DOI: 10.1111/bph.15695] [Reference Citation Analysis]
130 Xu J, Liu S, Cui Z, Wang X, Ning T, Wang T, Zhang N, Xie S, Min L, Zhang S, Liang C, Zhu S. Ferrostatin-1 alleviated TNBS induced colitis via the inhibition of ferroptosis. Biochem Biophys Res Commun 2021;573:48-54. [PMID: 34388454 DOI: 10.1016/j.bbrc.2021.08.018] [Reference Citation Analysis]
131 Kim HJ, Eom JY, Choi SH, Seo HJ, Kwun IS, Chun IJ, Sung J, Lim JH, Kim J, Song BJ, Lee CH, Kim DK, Baek MC, Cho YE. Plum Prevents Intestinal and Hepatic Inflammation in the Acute and Chronic Models of Dextran Sulfate Sodium-Induced Mouse Colitis. Mol Nutr Food Res 2022;:e2101049. [PMID: 35476900 DOI: 10.1002/mnfr.202101049] [Reference Citation Analysis]